ALKBH5 drives glycolysis in resistant breast cancer cells by mediating YTHDF2-dependent m6A demethylation of GLUT4 mRNA, which stabilizes the transcript and enhances glucose metabolism [84]. The gene discussed is ALKBH5; the disease is breast cancer.